BFA
RGLS

BlackRock Fund Advisors’s Regulus Therapeutics RGLS Stock Holding History

BlackRock Fund Advisors’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.72M Sell
10,084
-4,658
-32% -$1.51M ﹤0.01% 3104
2016
Q3 		$5.84M Buy
14,742
+750
+5% +$309K ﹤0.01% 2777
2016
Q2 		$4.85M Buy
13,992
+2,132
+18% +$1.53M ﹤0.01% 2830
2016
Q1 		$9.86M Buy
11,860
+421
+4% +$335K ﹤0.01% 2357
2015
Q4 		$12M Sell
11,439
-904
-7% -$906K ﹤0.01% 2341
2015
Q3 		$9.69M Buy
12,343
+607
+5% +$623K ﹤0.01% 2386
2015
Q2 		$15.4M Buy
11,736
+2,905
+33% +$4.69M ﹤0.01% 2269
2015
Q1 		$18M Buy
8,831
+512
+6% +$1.11M ﹤0.01% 2127
2014
Q4 		$16M Buy
8,319
+1,211
+17% +$2.15M ﹤0.01% 2188
2014
Q3 		$5.83M Buy
7,108
+31
+0.4% +$26.2K ﹤0.01% 2660
2014
Q2 		$6.83M Buy
7,077
+275
+4% +$236K ﹤0.01% 2650
2014
Q1 		$7.36M Buy
6,802
+489
+8% +$542K ﹤0.01% 2585
2013
Q4 		$5.6M Buy
6,313
+3,896
+161% +$3.35M ﹤0.01% 2754
2013
Q3 		$2.73M Buy
2,417
+548
+29% +$647K ﹤0.01% 3069
2013
Q2 		$2.2M Buy
+1,869
New +$1.78M ﹤0.01% 3076

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Fund Advisors's RGLS Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Regulus Therapeutics (RGLS) stake by 32% in Q4 2016, selling an estimated $1.51M and leaving 10,084 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #3104.

BlackRock Fund Advisors first reported a position in RGLS in Q2 2013 and has held it in 15 quarters since. The position peaked at $18M in Q1 2015. 68 funds tracked by Wall St. Rank hold RGLS as of Q4 2016.

  • BlackRock Fund Advisors held 10,084 shares of Regulus Therapeutics worth $2.72M as of Q4 2016.
  • BlackRock Fund Advisors sold 4,658 Regulus Therapeutics shares in Q4 2016, an estimated $1.51M.
  • Regulus Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3104 holding.
  • BlackRock Fund Advisors first reported a position in Regulus Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Regulus Therapeutics position peaked at $18M in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.